Study: Many Medicare Enrollees Not Receiving Recommended RA Drugs

A new study published in the Journal of the American Medical Association found that more than one-third of the 93,000 Medicare recipients who receive treatment for rheumatoid arthritis (RA) did not receive recommended disease-modifying anti-rheumatic drugs, or DMARDs.

Additionally, blacks, men, people living in poorer areas and residents of the Middle and South Atlantic regions are less likely to receive DMARDs. The study's lead author called this disparity "unacceptable."

To learn more, click here.